These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24910270)

  • 1. A double-blind vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of melasma in females.
    Katoulis A; Alevizou A; Soura E; Mantas N; Bozi E; Gregoriou S; Makris M; Rigopoulos D
    J Cosmet Dermatol; 2014 Jun; 13(2):86-90. PubMed ID: 24910270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
    Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
    Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of solar lentigines.
    Katoulis AC; Alevizou A; Bozi E; Makris M; Zafeiraki A; Mantas N; Kousta F; Mistidou M; Kanelleas A; Stavrianeas NG
    Clin Exp Dermatol; 2010 Jul; 35(5):473-6. PubMed ID: 19874316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a novel hydroquinone-free skin-brightening cream in patients with melasma.
    Gold MH; Biron J
    J Cosmet Dermatol; 2011 Sep; 10(3):189-96. PubMed ID: 21896130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A split-face, double-blind, randomized and placebo-controlled pilot evaluation of a novel oligopeptide for the treatment of recalcitrant melasma.
    Hantash BM; Jimenez F
    J Drugs Dermatol; 2009 Aug; 8(8):732-5. PubMed ID: 19663110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in the appearance of facial hyperpigmentation by topical N-undecyl-10-enoyl-L-phenylalanine and its combination with niacinamide.
    Bissett DL; Robinson LR; Raleigh PS; Miyamoto K; Hakozaki T; Li J; Kelm GR
    J Cosmet Dermatol; 2009 Dec; 8(4):260-6. PubMed ID: 19958429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the efficacy and tolerance of a new combination of retinoids and depigmenting agents in the treatment of melasma.
    Truchuelo MT; Jiménez N; Jaén P
    J Cosmet Dermatol; 2014 Dec; 13(4):261-8. PubMed ID: 25399618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of 20% azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma in dark-skinned patients.
    Sarkar R; Bhalla M; Kanwar AJ
    Dermatology; 2002; 205(3):249-54. PubMed ID: 12399672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study using reflectance confocal microscopy (RCM) in the assessment of a novel formulation for the treatment of melasma.
    Tsilika K; Levy JL; Kang HY; Duteil L; Khemis A; Hughes R; Passeron T; Ortonne JP; Bahadoran P
    J Drugs Dermatol; 2011 Nov; 10(11):1260-4. PubMed ID: 22052305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.
    Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM
    Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel skin brightener used as monotherapy for moderate melasma in skin of color.
    Grimes PE
    J Drugs Dermatol; 2014 Mar; 13(3):364-6. PubMed ID: 24595584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies.
    Fowler J; Jackson M; Moore A; Jarratt M; Jones T; Meadows K; Steinhoff M; Rudisill D; Leoni M
    J Drugs Dermatol; 2013 Jun; 12(6):650-6. PubMed ID: 23839181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
    Taylor SC; Torok H; Jones T; Lowe N; Rich P; Tschen E; Menter A; Baumann L; Wieder JJ; Jarratt MM; Pariser D; Martin D; Weiss J; Shavin J; Ramirez N
    Cutis; 2003 Jul; 72(1):67-72. PubMed ID: 12889718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical isotretinoin for melasma in Thai patients: a vehicle-controlled clinical trial.
    Leenutaphong V; Nettakul A; Rattanasuwon P
    J Med Assoc Thai; 1999 Sep; 82(9):868-75. PubMed ID: 10561942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial.
    Lee JH; Park JG; Lim SH; Kim JY; Ahn KY; Kim MY; Park YM
    Dermatol Surg; 2006 May; 32(5):626-31. PubMed ID: 16706756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of hydroquinone-free skin-lightening cream for photoaging.
    Dreher F; Draelos ZD; Gold MH; Goldman MP; Fabi SG; Puissegur Lupo ML
    J Cosmet Dermatol; 2013 Mar; 12(1):12-7. PubMed ID: 23438137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical 10% zinc sulfate solution for treatment of melasma.
    Sharquie KE; Al-Mashhadani SA; Salman HA
    Dermatol Surg; 2008 Oct; 34(10):1346-9. PubMed ID: 18616534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of the safety and efficacy of 75% mulberry (Morus alba) extract oil versus placebo as a topical treatment for melasma: a randomized, single-blind, placebo-controlled trial.
    Alvin G; Catambay N; Vergara A; Jamora MJ
    J Drugs Dermatol; 2011 Sep; 10(9):1025-31. PubMed ID: 22052272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
    Gonzalez P; Vila R; Cirigliano M
    J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.